期刊文献+

肝硬化患者治疗前后可溶性细胞间黏附分子-1水平变化及其临床意义 被引量:2

Serum soluble intercellular adhesion molecule-l and its clinic significance in patients with liver cirrhosis
在线阅读 下载PDF
导出
摘要 目的:探讨肝硬化患者治疗前后血清可溶性细胞间黏附分子-1(sICAM-1)水平变化与肝细胞损伤的关系。方法:用酶联免疫吸附试验检测50例肝硬化患者和20例正常对照者血清sICAM-1水平。结果:肝硬化患者血清sICAM-1水平高于正常对照组(t=2.874,P<0.01);肝硬化患者血清sICAM-1水平与谷草转氨酶(GOT)水平呈正相关(r=0.275,P<0.05),与血清白蛋白(ALB)水平呈负相关(r=-0.4812,P<0.01);从ChildA级到ChildC级,血清sICAM-1水平逐步升高(r=0.3698,P<0.05);重组人生长激素(rhGH)治疗组和常规治疗组治疗后GOT、血尿素氮(BUN)、总胆红素(SB)、肌酐(Cr)、sICAM-1水平均低于治疗前;rhGH治疗组治疗后BUN、Cr、sICAM-1水平较常规治疗组下降明显。rhGH治疗组和常规治疗组显效率、有效率、无效率分别为45.45%、36.36%、18.18%和36.36%、45.45%、27.27%。结论:肝硬化患者血清sICAM-1水平增高与肝细胞损伤、肝功能障碍有关,血清sICAM-1水平监测可作为临床观察肝硬化患者病变活动的重要免疫学指标。 Objective: To investigate the level of serum soluble intercellular adhesion molecule-l(sICAM-1) and assess its role in liver function injury of cirrhosis. Methods: The sICAM-1 was measured by enzyme linked immunosorbent assay in serum samples collected from 50 liver cirrhosis patients and 20 healthy controls. Liver function tests performed in all samples. Results: Serum levels of sICAM-1 were signifi-cantly increased in patients with liver cirrhosis compared with healthy controls(t=2.874, P<0.01). Serum levels of sICAM-1 correlated positively with glutamic oxaloacetic transaminase(GOT)(r=0.2754, P<0.05) and negative with albumin(ALB) (r=-0.4812, P<0.01). Serum levels of sICAM-1 were correlated positively(r= 0.3698, P<0.05) with assessment score of disease severity(Child classification). The contents of GOT, blood urea nitrogen(BUN), superfamily bilirubin(SB), creatinine(Cr), sICAM-1 were obviously lower than that of pretreatment. The contents of BUN、Cr、sICAM-1 comparision between recombination human growth hormone(rhGH) group and routine group in the after treatment were front obviously lower than that latter. The apparent efficiency, efficiency and inefficiency were 45.45%, 36.36% and 18.18% in rhGH group. The apparent efficiency, efficiency and inefficiency were 36.36%, 45.45%, and 27.27% in routine group. Conclusion:sICAM-1 is markedly elevated in liver cirrhosis and correlated with parameters of liver func-tion. sICAM-l may be useful in assessing the immunopathology of the disease process in liver cirrhosis.
出处 《国外医学(放射医学核医学分册)》 2005年第3期118-120,共3页 Foreign Medical Sciences(Section of Radiation Medicine and Nuclear Medicine)
关键词 肝硬化 细胞间黏附分子-1 酶联免疫吸附试验 肝功能试验 liver cirrhosis intercellular adhesion molecule-l enzyme linked immunosorbent assay liver function test
  • 相关文献

参考文献4

二级参考文献18

  • 1蒋俊康,任进民.应高度重视人血白蛋白制剂所致的不良反应[J].中国医院药学杂志,1994,14(10):476-477. 被引量:9
  • 2Moller S, Juul A, Becket U, et al. Concentrations, release, and disposal of insulin - like growth factor (IGF) - binding proteins (IGFBP), IGF - I , and growth hormone in different vascular beds in patients with cirrhosis[J] .J Clin Endocrinol Metab, 1995
  • 3Boisclair YR, Wang J, Shi J, et al. Role of suppressor of cytokines signailing- 3 in mediating the inhibitory effects of interleukin - 1 beta on the growth hormone - dependent transcription of the acid - labile subunit gene in liver cells[J] .J Bio Chem,
  • 4Donaghy A, Ross R, Wicks C, et al. Growth hormone therapy in patients with cirrhosis: a pilot study of efficacy and safety[J]. Gastroenterology, 1997,113:1617 - 22.
  • 5Chang TC, Lin JJ, Yu SC, et al. Absence of growth - hormone receptor in hepatocellular carcinoma and cirrhotic liver[J]. Hepatology, 1990,11:123 - 126.
  • 6Strand P, Carlsson L, Rash K, et al. Growth homone induces CCAT/enhancer binding protein α(C/EBP α) in cultured rat hepatocytes [J]. J Hepatol, 2000,32:618 - 626.
  • 7王洪涛 陈双 等.实验性肝硬化过程中生长激素受体的动态变化[J].中国实用外科杂志,1999,19:58-58.
  • 8Donaghy A, Ross R, Wicks C, et al. Growth hormone therapy in patients with cirrhosis:Apilot study of efficacy and safety[J].Gastroenterology,1997,113:1617~1622.
  • 9Moller S, Bedker U, Gronbeek M, et al. Short-term effect of recombinant human growth hormone in patients with alcoholic cirrhosis[J].Hepatol,1994,21:710~713.
  • 10Sassolas G. Potential therapeutic applications of growth hormone in adult[J].Horm Res,1994,42:72~74.

共引文献36

同被引文献12

  • 1侯振江,牟召新.细胞间黏附分子及其在肝脏病诊疗中的应用[J].医学综述,2004,10(8):480-482. 被引量:3
  • 2刘凡,黄志华.可溶性细胞间黏附分子与胆汁淤积[J].国外医学(流行病学.传染病学分册),2005,32(6):380-381. 被引量:1
  • 3Samransarnruajkit R, Prapphal N, Deelodegenavong J, et al. Plasma soluble intercellular adhesion molecule-1 (slCAM-1) in pediatric AR138 during high frequency oscillatory ventilation: A predictor of mortality[J]. Asian Pac J Allergy Immunol,2005,23(4) : 181 - 188.
  • 4Hillstron J, Duane WC, Eekfeldt JH, et al. Lack of benefit of ursodeoxyeholie acid in drug- induced eholestasis in the rat [ J ]. Proc Soc Exp Biol Med,1992,200(1):122-126.
  • 5Wu et Davis PA, Luketie VA, et al. A review of the physiological and irnmunologieal functions of biliary epithelial cells: Targets for primary biliary cirrhosis, primary sclerosing eholangitis and drug - induced duetopenias[ J ]. Clin Dev Immunol,2004,11 (3 - 4) :205 - 213.
  • 6Bostantjopoulou S, Katsarou Z, Frangia T, et al. Endothelial function markers in parkinsonian patients with hyperhomocysteinemia [ J ]. J Clin Neurosci,2005,12(6):669-672.
  • 7Zajkowska J M, lzycka A, Jablonska E, et al. Serum and cerebrospinal concentrations of sICAM- 1, sICAM - 2, sICAM - 3 in neuroborreliosis and tick borne encephalitis preliminary report [ J ]. Pol Merkuriusz Lek, 2005,19(110) : 152 - 157.
  • 8EI- Gohary AM, Fawaz NA, Hassoba HM, et al. Soluble ICAM-1 in patients with chronic hepatitis C infection:A prognostic marker of disease aetivity[J]. Egypt J Immunol, 2004 ,11( 2 ) :109 - 119.
  • 9Polzien F, Ramadori G. Increased intercellular adhesion molecule-1 serum concentration in cholestasis [ J ]. J Hepatol, 1996, 25 ( 6 ) :877 - 886.
  • 10Kossor DC, Meunier PC, Handler JA, et al. Temporal relationship of changes in hepatobiliary function and morphology in rats following alpha- naphthylisothiocyanate ( ANIT ) administration [ J ]. Toxicol Appl Pharmacol, 1993,119( 1 ) : 108 - 114.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部